erythromycin has been researched along with Ventricular Fibrillation in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dechering, DG; Eckardt, L; Ellermann, C; Fehr, M; Frommeyer, G; Kochhäuser, S; Sterneberg, M | 1 |
Guslits, B; MacDonald, LL; Orban, Z; Peters, MA | 1 |
de Koning, J; Hamer, B; Thompson, J; van der Hoeven, H | 1 |
3 other study(ies) available for erythromycin and Ventricular Fibrillation
Article | Year |
---|---|
Antiarrhythmic effect of antazoline in experimental models of acquired short- and long-QT-syndromes.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Antazoline; Anti-Bacterial Agents; Arrhythmias, Cardiac; Disease Models, Animal; Erythromycin; Histamine H1 Antagonists; Isolated Heart Preparation; Long QT Syndrome; Membrane Transport Modulators; Pinacidil; Rabbits; Refractory Period, Electrophysiological; Sotalol; Torsades de Pointes; Ventricular Fibrillation | 2018 |
Erythromycin-induced cardiac toxicity.
Topics: Adult; Arrhythmia, Sinus; Bradycardia; Cardiac Complexes, Premature; Erythromycin; Female; Humans; Hypotension; Injections, Intravenous; Torsades de Pointes; Ventricular Fibrillation | 1995 |
Erythromycin-induced torsades de pointes and ventricular fibrillation in a patient with Legionella pneumonia.
Topics: Aged; Erythromycin; Female; Humans; Legionnaires' Disease; Torsades de Pointes; Ventricular Fibrillation | 1994 |